The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
The NCI Transition Career Development Award (K22 Independent Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.
This FOA is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants proposing a clinical trial, a clinical trial feasibility study, or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOAs (PAR-21-111 or PAR-21-318).
K Series Deadlines: Feb. 12, Jun. 12, Oct. 12
PAR-21-128 Expiration Date March 15, 2024
Any candidate with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) and who has at least 2 years, but, no more than 8 years of mentored, non-independent training experience after the terminal research doctoratel or clinical degree, is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities, are always encouraged to apply for NIH support. Such individuals may also be eligible for the NCI Transition Career Development Award to Promote Diversity (K22) and are advised to contact the NCI Center to Reduce Cancer Health Disparities.
Multiple PDs/PIs are not allowed.
By the time of award, the PI of a K22 award must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status.
At the time of the initial application submission (or resubmission), candidates for this award must (1) have earned a terminal research doctorate or clinical degree (including PhD, MD, DO, DC, ND, DDS, DMD, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) or a combined research doctorate/clinical degree; (2) have at least 2 years of postdoctoral, or its equivalent, training in cancer research (e.g., postdoctoral fellow, postdoctoral associate, clinical fellow, clinical associate, or equivalent); (3) have no more than a total of 8 years of mentored, non-independent research training experience after the terminal research doctorate or clinical degree; (4) have not already obtained an individual career development award or research project grant (except R03) from the Federal Government; and (5) have not already had or have a tenure-track faculty position, or its equivalent.
Individuals are eligible for a K22 award if they have been, or currently are, the PD/PI of an NIH R03 or a PHS or non-Federal award that duplicates the specific aims or research goals of an R03 grant.
Postdoctoral fellows in mentored, non-independent training positions, but who have job titles such as research associate, instructor, or the equivalent, are encouraged to obtain confirmation of their eligibility before they begin to prepare their applications. It is incumbent upon the candidate to provide evidence that he/she is in a mentored, non-independent position.
A clinical faculty member who does not hold an independent research faculty position may be eligible for the K22 award are encouraged to obtain confirmation of their eligibility before they begin to prepare their applications.
Investigators in independent positions in Mathematics, Physical Sciences and/or Engineering and who wish to re-orient to cancer-focused research careers are encouraged to apply. Investigators in such positions are encouraged to obtain confirmation of their eligibility before they begin to prepare their applications.
Mentored, non-independent investigators in NIH intramural laboratories and other eligible agencies of the Federal Government are eligible to apply for the NCI K22 award.